PatriciaYvonneFechnerMD

Medical Director, Differences in Sex Development Program at Seattle Children's, Medical Director, Center of Excellence for CAH at Seattle Children’s, Co-Director, Turner Syndrome Clinic at Seattle Children’s

Join to view full profile

Dr. Fechner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Fechner's full profile

Already have an account?

Office
4800 Sand Poin Way Ne
M/S OC.7.820
Seattle, WA 98105
Phone+1 206-987-5037

Fax+1 206-985-3373

Summary

Patricia Fechner, MD, is attending physician at Seattle Childrens Hospital and professor of pediatrics at the University of Washington School of Medicine. Her clinical and research interests include Turner syndrome, androgen insensitivity syndrome and other disorders of sex determination as well as growth hormone and IGF-1 deficiency. She is the medical director of the DSD program and co-director of the Turner syndrome clinic. She serves as the contributing editor for the section of endocrinology AAP Grand Rounds and as consulting editor for GeneReviews.

Education & Training

Johns Hopkins UniversityFellowship, Pediatric Endocrinology, 1989 - 1993
University of California (Irvine)/Children's Hospital of Orange CountyResidency, Pediatrics, 1986 - 1989
Northwestern University The Feinberg School of MedicineClass of 1986

Certifications & Licensure

CA State Medical License 1988 - 2026
WA State Medical License 2006 - 2025
MD State Medical License 1993 - 2000
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Endocrinology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Fellow (FACE) American Association of Clinical Endocrinology

Clinical Trials

Decision Support for Parents Receiving Information About Child's Rare Disease Start of enrollment: 2013 Jun 01
Completed
Phase 2 Study of LUM-201 in Children With Growth Hormone Deficiency (OraGrowtH210 Trial) Start of enrollment: 2020 Dec 31
Active, not recruiting
Phase 2
Global Safety and Efficacy Registration Study of Crinecerfont in Pediatric Patients With Classic Congenital Adrenal Hyperplasia (CAHtalyst Pediatric Study) Start of enrollment: 2021 Jun 25
Active, not recruiting
Phase 3

Publications & Presentations

PubMed

Prevalence, diagnostic features, and medical outcomes of females with Turner syndrome with a trisomy X cell line (45,X/47,XXX): Results from the InsighTS Registry.
Natalia Klamut, Samantha Bothwell, Alexandra E Carl, Vaneeta Bamba, Jennifer R Law
American Journal of Medical Genetics. Part A. 2024-12-01
Gender-Diverse Youth with Turner Syndrome: Special Management Considerations.
Kelsey B Eitel, Anna Zenno, Carolina Di Blasi, Patricia Y Fechner, Juanita K Hodax
JCEM Case Reports. 2024-05-01
2 citations
Development and validation of a computable phenotype for Turner syndrome utilizing electronic health records from a national pediatric network.
Sarah D Huang, Vaneeta Bamba, Samantha Bothwell, Patricia Y Fechner, Anna Furniss
American Journal of Medical Genetics. Part A. 2024-04-01

Lectures

Turner Syndrome: Growth, Puberty, and Fertility (Repeat)
ENDO 2019 - New Orleans, LA - 3/25/2019
Turner Syndrome: Growth, Puberty, and Fertility Add to Itinerary
ENDO 2019 - New Orleans, LA - 3/25/2019

Professional Memberships

American Association of Clinical Endocrinologists - AACE
Fellow